CE –marked

﹒BfArM Test-ID: AT981/21

﹒Specimen: Nasopharyngeal/nasal specimen

﹒Sensitivity(NP): 96.3%

﹒Specificity(NP): 100%

﹒Sensitivity(N): 95.5%

﹒Specificity(N): 99.6%

AQ⁺ HIV Ag/Ab Combo Rapid Test is an in vitro, qualitative immunoassay for the detection of Human Immunodeficiency Virus type 1 (HIV-1) antibody, type 2 (HIV-2) antibody and free HIV-1 p24 antigen in human whole blood (venous and fingertip), serum，plasma. It is intended for use as a point-of-care test to aid in the diagnosis of HIV infection.

INTENDED USE

The kit is intended to qualitatively detect Toxoplasma IgM, Toxoplasma IgG, Cytomegaloviru IgM, Cytomegaloviru IgG and Rubella virus IgG in human serum, plasma or whole blood in vitro. It is suitable for clinical auxiliary diagnosis of Toxoplasma infection, Cytomegalovirus infection and Rubella virus infection as well as their epidemiological inverstigation.

CE-marked

Sensitivity: 93.10%

Specificity: 100%

Specimen type: nasopharyngeal swabs

INTENDED USE

The AQ+ Rapid COVID-19/Flu Combo Test is a colloidal gold enhanced, rapid immunochromatographic assay for qualitative detection of antigens to SARS-CoV-2 and Influenza A and influenza B present in human nasopharyngeal/nasal specimens. The test is used as an aid in the diagnosis of COVID-19 infection and/or Influenza A and Influenza B.

CE-marked

Sensitivity:

The Rapid Troponin l Test can detect cTnl in whole blood, serum or plasma with concentration of 0.5ng/ml or greater.

CE-marked

Specimen: whole blood, serum or plasma

Sensitivity: 100%

Specificity: 99.43%

ISO 13485